Actuate Therapeutics (ACTU) Retained Earnings (2023 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Retained Earnings of $162.5 million for Q4 2025, up 22.68% year-over-year from $132.5 million in Q4 2024, and up 208.32% quarter-over-quarter from -$150.1 million in Q3 2025.
Actuate Therapeutics (ACTU) Retained Earnings (2023 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Retained Earnings for 3 consecutive years, with $162.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Retained Earnings rose 22.68% year-over-year to $162.5 million; the TTM figure through Dec 2025 stood at $162.5 million (up 22.68% YoY), while the FY2025 annual figure was $162.5 million, up 22.68% from the prior year.
- Retained Earnings climbed to $162.5 million in Q4 2025 per ACTU's latest filing, from -$150.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at $162.5 million in Q4 2025 and bottomed at -$150.1 million in Q3 2025.
- Historically, Retained Earnings has averaged $20.7 million across 3 years, with a median of $68.5 million in 2024.
- Annual changes were most pronounced in 2024 — Retained Earnings jumped 226.06% — and 2025, when it tumbled 2634.88%.
- Actuate Therapeutics' Retained Earnings stood at -$105.1 million in 2023, then surged by 226.06% to $132.5 million in 2024, then grew by 22.68% to $162.5 million in 2025.
- Business Quant data shows ACTU's Retained Earnings at $162.5 million in Q4 2025, -$150.1 million in Q3 2025, and -$144.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - | 4.38 Bn |
| 10 | Actuate Therapeutics | 29.84 Mn | 29.84 Mn | - | 166.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 162.53 Mn |
| Sep 30, 2025 | -150.05 Mn |
| Jun 30, 2025 | -144.65 Mn |
| Mar 31, 2025 | 133.61 Mn |
| Dec 31, 2024 | 132.48 Mn |
| Sep 30, 2024 | 131.29 Mn |
| Jun 30, 2024 | 5.71 Mn |
| Dec 31, 2023 | -105.09 Mn |